Castle Biosciences (CSTL) EPS (Weighted Average and Diluted): 2018-2024
Historic EPS (Weighted Average and Diluted) for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to $0.62.
- Castle Biosciences' EPS (Weighted Average and Diluted) fell 125.00% to -$0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.45, marking a year-over-year decrease of 314.29%. This contributed to the annual value of $0.62 for FY2024, which is 128.97% up from last year.
- According to the latest figures from FY2024, Castle Biosciences' EPS (Weighted Average and Diluted) is $0.62, which was up 128.97% from -$2.14 recorded in FY2023.
- In the past 5 years, Castle Biosciences' EPS (Weighted Average and Diluted) ranged from a high of $0.62 in FY2024 and a low of -$2.58 during FY2022.
- For the 3-year period, Castle Biosciences' EPS (Weighted Average and Diluted) averaged around -$1.37, with its median value being -$2.14 (2023).
- In the last 5 years, Castle Biosciences' EPS (Weighted Average and Diluted) tumbled by 157.14% in 2020 and then spiked by 128.97% in 2024.
- Castle Biosciences' EPS (Weighted Average and Diluted) (Yearly) stood at -$0.54 in 2020, then crashed by 129.63% to -$1.24 in 2021, then tumbled by 108.06% to -$2.58 in 2022, then increased by 17.05% to -$2.14 in 2023, then soared by 128.97% to $0.62 in 2024.